President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
Source link
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
Related Posts
Best Buy (BBY) Q1 2027 earnings
A person walks outside a Best Buy store on May 29, 2025 in Chicago, Illinois.…
Fintech firm Mercury hits $5.2 billion valuation after funding round
Immad Akhund, CEO and co-founder of the startup Mercury. Courtesy: Mercury Technologies Mercury, a fintech…
Laid-off GM employees tell of ominous email, severance and role of AI
DETROIT — An ominous email about an oddly timed 15-minute virtual meeting. A scripted message…